Skip to main content

Table 1 RNA precision study sample summary

From: Analytical validation of the PAM50-based Prosigna Breast Cancer Prognostic Gene Signature Assay and nCounter Analysis System using formalin-fixed paraffin-embedded breast tumor specimens

Intrinsic subtype

Estimated ROR score

Risk classification

Luminal A

30

Low

Luminal B #1

54

Intermediate

Luminal B #2

64

High

Basal-like

55

Intermediate

HER2-enriched

76

High

  1. Molecular characteristics of the five pooled breast tumor RNA samples used in the RNA precision study.
Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us